Genome Pioneer Deborah Nickerson Dies at 67

The University of Washington researcher leveraged data from the Human Genome Project to identify genes underlying various health conditions and advance precision medicine.

amanda heidt
| 3 min read
Deborah Nickerson
Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Deborah Nickerson, whose genomics research made her one of the most-cited American scientists of the past decade, died December 24 at age 67. Nickerson’s brother William tells The New York Times that her death was due to advanced metastatic abdominal cancer, which she had been diagnosed with less than a week before.

Throughout her career, Nickerson leveraged emerging technologies to sequence and analyze the genomes of thousands of healthy individuals of diverse ancestry. By layering these data over the annotated genome resulting from the Human Genome Project, she was able to pinpoint genes underlying conditions such as cardiovascular disease, autism, and the rare Miller syndrome.

“Her imprint on genomic medicine is profound,” Gail Jarvik, a professor of medicine and genome science at the University of Washington School of Medicine (UW Medicine), tells the Times. “Her role was in really helping us understand what changes in DNA among people meant, and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • amanda heidt

    Amanda Heidt

    Amanda was an associate editor at The Scientist, where she oversaw the Scientist to Watch, Foundations, and Short Lit columns. When not editing, she produced original reporting for the magazine and website. Amanda has a master's in marine science from Moss Landing Marine Laboratories and a master's in science communication from UC Santa Cruz.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo